Researchers used AI to analyze lab-grown brain organoids to map genetic mutations linked to autism. This dataset identifies specific cellular malfunctions that drive developmental differences. By pinpointing these biological triggers, the team provides a blueprint for targeted drug therapies. Practitioners can now test chemical interventions against precise genetic markers rather than broad symptoms.